Skip to main content
OpenTrials

Clinical trial condition

Joint Diseases

Explore clinical trials studying Joint Diseases. Study availability and eligibility vary by location and protocol.

10,308 public trials 1,271 recruiting studies
Refine in advanced search Browse all conditions

Joint Diseases trial results

Completed

A Study of Ixekizumab in Participants With Active Psoriatic Arthritis

NCT01695239

Conditions
Arthritis, Arthritis, Psoriatic, Bone Diseases, +11 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Birmingham, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Huntsville, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tuscaloosa, Alabama, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Little Rock, Arkansas, United States
View all 116 locations
View Trial Details
Completed

16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients

NCT02008916

Conditions
Ankylosis, Arthritis, Axial Spondyloarthritis, +8 more
Locations
  • Novartis Investigative Site Mobile, Alabama, United States
  • Novartis Investigative Site Mesa, Arizona, United States
  • Novartis Investigative Site Peoria, Arizona, United States
  • Novartis Investigative Site Upland, California, United States
View all 57 locations
View Trial Details
Completed

Adalimumab in Axial Spondyloarthritis (ASIM) - MRI and Biomarkers in Patients With Spondyloarthritis

NCT01029847

Conditions
Arthritis, Bone Diseases, Joint Diseases, +5 more
Locations
  • Dep. of medicine, Herlev Hospital Copenhagen, Denmark
  • Dep. of Radiology, Herlev Hospital Copenhagen, Denmark
  • Dep. of Rheumatology, Frederiksberg and Bispebjerg Hospitals Copenhagen, Denmark
  • Dep. of Rheumatology, Gentofte Hospital Copenhagen, Denmark
View Trial Details

Related conditions